Coronary artery disease and liver transplantation: The state of the art

The State of the Art he idea that liver disease is somehow protective T from atherosclerotic coronary artery disease (CAD) has been repeatedly shown not to be valid. In addition, the cardiovascular demands of end-stage liver disease, as well as the orthotopic liver transplantation (OLT) procedure itself, are such that a hindrance to myocardial oxygen supply may be disastrous. This article attempts to summarize the state-of-the-art knowledge about the incidence and preoperative detection of CAD in the OLT population, as well as the results of O L T in these patients.